mutation ReceivesAction associated with primary resistance
Typicality: 0.274
Saliency: 0.058

Facets 2
to erlotinib 4 location
to inis 2 location
Open triples 1
mutation → be associated with → primary resistance 4
Sentiment analysis
negative neutral positive
0.246 0.698 0.056
Other statistics
Raw frequency 4
Normalized frequency 0.058
Modifier score 0.500
Perplexity 388.130